2654
P. J. Crowley et al. / Tetrahedron Letters 51 (2010) 2652–2654
3911–3913; (c) Son, J. K.; Kim, S. I.; Jahng, Y. Heterocycles 2001, 55, 1981–1986;
(d) Domon, L.; Le Coeur, C.; Grelard, A.; Thiery, V.; Besson, T. Tetrahedron Lett.
2001, 42, 6671–6674; (e) Zhou, Z.-L.; Navratil, J. M.; Cai, S. X.; Whittemore, E.
R.; Espitia, S. A.; Hawkinson, J. E.; Tran, M.; Woodward, R. M.; Weber, E.; Keana,
J. F. W. Bioorg. Med. Chem. 2001, 9, 2061–2071.
F
F
F
F
F
F
Cl
N
S
c-Pent-SH,
NaH
N
N
6. (a) Thummel, R. P. Synlett 1992, 1–12; (b) Cheng, C.-C.; Yan, S.-J. Org. React.
1982, 28, 37–201.
7. Temple, C.; Kussner, C. L.; Montgomery, J. A. J. Org. Chem. 1971, 36, 2974–2978.
8. Crowley, P. J.; Dobler, M.; Müller, U.; Williams, J. WO 2004/056829 (Syngenta);
Chem. Abstr. 2004, 141, 89107.
N
F
F
F
F
N
25 %
N
Cl
N
N
Cl
9
12
c-Hex-MgCl, ZnBr2,
LiCl, CuCN
9. Typical synthesis procedure for compound 2:
A
solution of 2,4,6-
NaOMe
57 %
trifluorophenylacetyl chloride (10.5 g, 50 mmol) in 30 ml of dichloromethane
is added at 0 °C to a solution of 6-amino-[1,2,4]triazine-5-carboxylic acid ethyl
ester7 (6, 8.5 g, 50 mmol), pyridine (4.0 g, 50 mmol), and catalytic amounts of
4-N,N-dimethylaminopyridine in 170 ml of dichloromethane. The resulting
suspension is stirred for 16 h at room temperature and then extracted with 2 N
hydrochloric acid and water. The organic layer is washed with brine, dried over
sodium sulfate, and evaporated. The remainder is purified by chromatography
on silica gel, using cyclohexane/ethyl acetate 3:1 as eluent, to give 6-[2-(2,4,6-
trifluorophenyl)-acetylamino]-[1,2,4]triazine-5-carboxylic acid ethyl ester (7,
12 g, 35 mmol, 70%) as a viscous oil, which solidified. Mp 106–107 °C. 1H NMR
(CDCl3): d (ppm) 1.46 (t, 3H, J = 7.2 Hz), 4.10 (s, 2H), 4.48 (q, 2H, J = 7.2 Hz), 6.73
(t, 2H, J = 8.5 Hz), 9.62 (s, 1H), 10.03 (s, 1H). MS m/z: 341 (C14H11F3N4O3+H)+. A
mixture of 7 (6.0 g, 18 mmol) and anhydrous potassium carbonate (3.75 g,
27 mmol) in 50 ml of N,N-dimethylformamide is stirred for 2 h at 80 °C.
Subsequently the reaction mixture is cooled, poured into water, and acidified
to pH 5 with 5 N hydrochloric acid. After extraction with ethyl acetate, the
organic layer is dried over sodium sulfate and evaporated to give an orange
solid, which was triturated with tert-butyl methyl ether to deliver 5-hydroxy-
4 %
F
F
F
O
N
N
N
N
F
N
N
Cl
N
N
Cl
13
14
i-PrNH2,
MW (50 W, 10 min)
NaCN,
MW (50 W,
10 min)
62 %
79 %
F
F
F
O
O
6-(2,4,6,-trifluorophenyl)-8H-pyrido[3,2-e][1,2,4]triazin-7-one
(8,
4.7 g,
16 mmol, 90%) as a yellow powder. Mp 170–171 °C. 1H NMR ((CD3)2SO): d
(ppm) 7.29 (t, 2H, J = 8.4 Hz), 9.73 (s, 1H), 12.89 (s, 1H). MS m/z: 293
(C12H5F3N4O2ÀH)+. A solution of 8 (4.0 g, 14 mmol) in 20 ml of phosphorus
oxychloride was heated to 85 °C for 2 h. The reaction mixture is cooled to 55 °C
and the solvent is removed at this temperature in vacuo. The remaining oil is
diluted with ethyl acetate and washed with brine and aqueous sodium
bicarbonate solution. The organic layer is dried over sodium sulfate and
evaporated, the residue is purified by chromatography using cyclohexane/ethyl
acetate 3:1 as eluents to deliver 5,7-dichloro-6-(2,4,6-trifluorophenyl)-
pyrido[3,2-e][1,2,4]triazine (9, 3.9 g, 12 mmol, 88%) as reddish solid. Mp 143–
144 °C. 1H NMR (CDCl3): d (ppm) 6.96 (t, 2H, J = 8.5 Hz), 10.24 (s, 1H). MS m/z:
332 (C12H3Cl2F3N4+H)+. A suspension of 9 (2.9 g, 8.7 mmol) and spray-dried
potassium fluoride (1.5 g, 26 mmol) in 10 ml of sulfolane is heated to 130 °C for
2 h. The reaction mixture is cooled, poured into water, and extracted with ethyl
acetate. The combined organic layer is washed with brine, dried over sodium
sulfate, and evaporated. The residue is purified by chromatography using
cyclohexane/ethyl acetate 3:1 as eluents to give 5,7-difluoro-6-(2,4,6-
trifluorophenyl)-pyrido[3,2-e][1,2,4]triazine (10, 1.7 g, 5.8 mmol, 67%) as
N
N
F
N
N
N
N
N
N
N
NH
15
16
Scheme 2. Synthesis of the trisubstituted pyrido[3,2-e][1,2,4]triazine 2a.
pyrazines could be regioselectively replaced by amino, alkyl, alk-
oxy, and alkylthio groups.
References and notes
1. Crowley, P. J.; Lamberth, C.; Müller, U.; Wendeborn, S.; Nebel, K.; Williams, J.;
Sageot, O.-A.; Carter, N.; Mathie, T.; Kempf, H.-J.; Godwin, J.; Schneiter, P.;
Dobler, M. R.. Pest Manag. Sci. 2010, 66, 178–185.
2. (a) Zhou, J.; Giannakakou, P. Curr. Med. Chem. Anticancer Agents 2005, 5, 65–71;
(b) Honore, S.; Pasquier, E.; Braguer, D. Cell Mol. Life Sci. 2005, 62, 3039–3056;
(c) Jordan, M. A.; Wilson, L. Nat. Rev. Cancer 2004, 4, 253–265; (d) Li, Q.; Sham,
H. L. Expert Opin. Ther. Patents 2002, 12, 1663–1702; (e) Jordan, M. A. Curr. Med.
Chem. Anticancer Agents 2002, 2, 1–17.
3. (a) Reich, M. F.; Fabio, P. F.; Lee, V. J.; Kuck, N. A.; Testa, R. T. J. Med. Chem. 1989,
32, 2474–2485; (b) Ple, N.; Queguiner, G.; Pastour, P. CR Hebd. Seances Acad. Sci.,
Ser. C 1976, 283, 487–489; (c) Messmer, A.; Gelleri, A.; Benko, P.; Pallos, L. Magy.
Kem. Foly. 1976, 82, 173–179; (d) Benko, P.; Messmer, A.; Gelleri, A.; Pallos, L.
Acta Chim. Acad. Sci. Hung. 1976, 90, 285–299; (e) Gelleri, A.; Messmer, A.;
Benko, P.; Pallos, L. Acta Chim. Acad. Sci. Hung. 1976, 90, 301–311; (f) Lewis, A.;
Shepherd, R. G. J. Heterocycl. Chem. 1971, 8, 41–46.
yellow powder. Mp 160–161 °C. 1H NMR (CDCl3):
d (ppm) 6.95 (t, 2H,
J = 8.6 Hz), 10.21 (s, 1H). MS m/z: 299 (C12H3F5N4+H)+. 10 (0.25 g, 0.83 mmol)
is added to a mixture of (S)-2,2,2,-trifluoroisopropylamine (0.21 g, 1.84 mmol)
and catalytic amounts of 4-N,N-dimethylaminopyridine in 3 ml of N,N-
dimethylformamide. The reaction mixture is stirred for 16 h at room
temperature, then poured into ethyl acetate, and washed with brine. The
organic layer is dried over sodium sulfate and evaporated, the residue is
purified by chromatography on silica gel, using cyclohexane/ethyl acetate 3:1
as
eluents
to
deliver
[7-fluoro-6-(2,4,6-trifluorophenyl)-pyrido[3,2-
e][1,2,4]triazin-5-yl]-((S)-2,2,2-trifluoro-1-methyl-ethyl)-amine (2a, 0.15 g,
0.38 mmol, 46%) as a yellow solid. Mp 93–94 °C. 1H NMR (CDCl3): d (ppm)
1.45 (d, 3H, J = 7.0 Hz), 4.21 (dt, 1H, J = 9.2 Hz), 6.83–6.98 (m, 2H), 9.96 (s, 1H).
MS m/z: 392 (C15H8F7N5+H)+.
10. (a)Microwaves in Organic Synthesis; Loupy, A., Ed.; Wiley-VCH: Weinheim,
2006; (b) Kappe, C. O.; Stadler, A. Microwaves in Organic and Medicinal
Chemistry; Wiley-VCH: Weinheim, 2005; (c)Microwave Assisted Organic
Synthesis; Lidström, P., Tierney, J. P., Eds.; Blackwell Scientific: Oxford, 2005.
4. Hisano, T. Org. Prep. Proced. Int. 1973, 5, 145–193.
5. For some recent applications of the Niementowski reaction see: (a) Alexandre,
F.-R.; Berecibar, A.; Wrigglesworth, R.; Besson, T. Tetrahedron 2003, 59, 1413–
1419; (b) Alexandre, F.-R.; Berecibar, A.; Besson, T. Tetrahedron Lett. 2002, 43,